Sernova Corp. (TSE:SVA – Get Free Report) shares were down 1.5% during trading on Thursday . The stock traded as low as C$0.32 and last traded at C$0.34. Approximately 182,500 shares changed hands during mid-day trading, an increase of 17% from the average daily volume of 156,507 shares. The stock had previously closed at C$0.34.
Analysts Set New Price Targets
Separately, Raymond James set a C$1.50 price objective on Sernova and gave the company a “market perform” rating in a research report on Thursday, April 4th.
Check Out Our Latest Research Report on Sernova
Sernova Trading Down 1.5 %
About Sernova
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
Read More
- Five stocks we like better than Sernova
- Want to Profit on the Downtrend? Downtrends, Explained.
- Celebrate July 4th with These Red, White, & Blue Chip Stocks
- What Are Dividend Contenders? Investing in Dividend Contenders
- AbbVie Stock: A Perfect Dip for Investors to Buy
- How to Invest in the Best Canadian StocksĀ
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.